" Doctors and patients all knew which group the patients had been assigned to, and this kind of "open-label" trial design could have introduced bias, potentially overestimating the effect of the drug, the researchers said. "
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
uncensored
2,694 posts
Posted by uncensored > 2022-02-19 14:28 | Report Abuse
Ai yo yo
Ai yo yo
Ai yo yo
Old story ...loooh... no longer an interesting laaa